1999
DOI: 10.1016/s0041-1345(99)00497-2
|View full text |Cite
|
Sign up to set email alerts
|

Rehospitalization needs in a cardiac transplantation unit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…reported 37% rehospitalization over 4 years among adult Htx recipients who survived at least 6 months post‐transplant, and Donovan et al. reported rehospitalization in 36% of adult patients in the first post‐transplant year . Both studies found that the most common indication for rehospitalization was infection (40% in both studies), with rejection being relatively rare at 12% and 14%, respectively .…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…reported 37% rehospitalization over 4 years among adult Htx recipients who survived at least 6 months post‐transplant, and Donovan et al. reported rehospitalization in 36% of adult patients in the first post‐transplant year . Both studies found that the most common indication for rehospitalization was infection (40% in both studies), with rejection being relatively rare at 12% and 14%, respectively .…”
Section: Discussionmentioning
confidence: 97%
“…reported rehospitalization in 36% of adult patients in the first post‐transplant year . Both studies found that the most common indication for rehospitalization was infection (40% in both studies), with rejection being relatively rare at 12% and 14%, respectively . Neither of those studies, however, analyzed hospitalization patterns in detail, and thus, a comparison of rehospitalization characteristics or outcomes for specific subgroups could not be made.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite its efficacy, the side effects of cyclosporine are especially pronounced; beyond producing disturbances in patients’ physiological, psychological and social wellbeing, cyclosporine may be a significant threat to the health and safety of transplant patients. Post‐transplantation complications commonly seen in the literature include rejection, infection, renal failure, hyperlipidaemia, hypertension, diabetes, osteoporosis, malignant tumours (Wagoner 1997, Cristobal et al. 1999, Augustine 2000, Donovan et al.…”
Section: Introductionmentioning
confidence: 99%
“…In general, there is significant morbidity in the first year after transplantation and the number of readmissions is also high. Cristobal et al. (1999) examined data from 212 patients who survived for at least six months after heart transplantation between 1984 and 1996.…”
Section: Introductionmentioning
confidence: 99%